News

Life sciences organizations rarely lack strategy. The harder challenge is turning an approved global idea into accurate, relevant assets across markets without losing speed, consistency or compliance at each handoff. Print makes that execution gap visible as materials pass through localization, approval, procurement, production and distribution.

The question, then, is not whether print is still relevant. It is whether each physical asset performs a necessary information task, and whether the operating model can deliver it reliably. In other words, channel choice should follow the information task, not precede it.

Give every channel a job

In a small HH Global study into how HCPs prefer to receive communications, responses indicated that print has a role as a high-quality channel. Unlike an email that disappears in a crowded inbox, a useful, printed piece can remain within a practice, be revisited and travel beyond its first recipient. Good print is passed among peers, teams and patients, extending its opportunity to be seen and used.

But repetition alone does not create engagement. Print that feels overtly ”markety” and without a clear use, can end up as waste. Relevance depends on the information task, the setting and the audience, rather than a predetermined channel preference. Relevance is also improved when the design and physical production signal care and utility.

For print, the answer may be a concise reference aid, a leave-behind that supports an HCP-patient conversation or material designed to move an initial glance into a deeper digital experience. High production quality matters when it reinforces usefulness and trust; it cannot rescue generic or poorly targeted content. Tailoring therefore extends beyond the message to format, information density, durability, distribution and the moment in which the material will be used.

This is where HH Global differs from an agency or consultancy. Strategy and creative advice can identify what a brand wants to communicate. HH Global carries audience insight into the practical decisions that determine whether the communication works: specification, adaptation, approval, sourcing, production and delivery. That connection makes insight actionable and improves the role print plays within the wider HCP journey.

Make compliant execution faster

Once the role is clear, governance determines whether it can be delivered at scale. Printed inventory creates cost and compliance risk when information changes, materials become obsolete or outdated versions remain in circulation. Smaller, targeted runs and on-demand production from pre-approved vendors can reduce that exposure and help teams respond to changing needs.

Standardized, harmonized templates held in a secure digital catalog can give markets access to current, approved assets while supporting faster, more accurate production. This is more than operational control. It is infrastructure that makes compliant execution repeatable, enabling governance to accelerate activation, not just police it.

As regional teams take greater ownership, the right model should combine global standards and visibility with local knowledge, production and adaptation.

In HH Global’s work with one leading pharmaceutical company, harmonization reduced POS unit production by 68% within a unified procurement model spanning 21 markets. This shows governance in practice: global visibility and common standards can remove unnecessary production while supporting consistent execution across markets.

Build resilience across markets

That model depends on a supply chain capable of handling varied demand across thousands of assets. HH Global’s Strategic Sourcing team manages a network of more than 8,000 suppliers worldwide, combining global scale with local knowledge. We can integrate existing vendors or provide access to our pre-approved network, helping clients protect quality, capacity and flexibility across markets.

In the US, supplier diversity can also be an important consideration in contracts with government agencies and healthcare providers. In Europe, changing environmental rules add another layer of execution complexity. Under the European Commission’s current timetable, the EU Deforestation Regulation applies from 30 December 2026 for large and medium operators and for certain micro and small operators already covered by the EU Timber Regulation, and from 30 June 2027 for most other micro and small operators.

The dates and detailed obligations may continue to evolve. Certified supply chains, auditing and traceability can support readiness, but they do not by themselves guarantee compliance with every EUDR requirement. The wider lesson is more durable: life sciences teams need supply-chain visibility and adaptable governance so regulatory change can be absorbed without rebuilding activation from the ground up.

Remove friction, not just cost

Execution gaps are also created by administrative complexity. HH Global’s continuous improvement process uses data and insight to examine how work moves through the print ecosystem and where effort, time and visibility are being lost.

For one global pharma client, HH Global consolidated 3,700 annual purchase orders—around 308 per month—into just 16 per month. This freed internal teams to focus on higher-value work and improved cost transparency. The significance goes beyond print savings: simplifying the operating model can create greater clarity and support speed to market.

Produce only what earns its place

Sustainability reinforces the same demand-led discipline. HH Global’s sustainability framework assesses total print spend to identify improvements and measurable KPIs. That can include material choices, recyclable or biodegradable substrates, reduced plastic and glue, and the balance between recycled and recyclable options. It also considers emissions from production and logistics to build a fuller picture of impact and potential reductions.

The strongest sustainability decision may be a different substrate, a shorter run, an on-demand model, a digital alternative or no asset at all. The objective is not to make more print appear greener, but to remove unnecessary volume and execute the remaining requirement responsibly.

For one recurring 900,000-unit print run, HH Global’s technical analysis identified an opportunity to reduce the client’s paper weight from 150 gsm to 120 gsm. The revised specification maintained the expected quality while delivering over 12% savings. The example demonstrates print innovation at scale: interrogating a specification against its real purpose, then using less material where the application allows it.

Conclusion

Print is a lens on a much bigger life sciences challenge. A sophisticated strategy creates little value if activation is slow, fragmented, difficult to govern or disconnected from the way HCPs and patients use information. Conversely, the right infrastructure can connect global intent with local relevance, compliant production, resilient sourcing and continuous improvement.

Learn how HH Global can help turn approved marketing strategy into relevant, compliant and scalable marketing activity across markets.